Skip to content

D&A at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$2B+13.1%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$270M+6.1%
Globus Medical logo
Globus MedicalGMED
$69.86M+6.4%
Alphatec Holdings logo
Alphatec HoldingsATEC
$19.14M-3.9%
SI-BONE, Inc. logo
SI-BONE, Inc.SIBN
$1.62M+26.5%
Medtronic logo
MedtronicMDT
$716M-14.8%

Other financials

Income statement

See full
Revenue$20.9M-36.5%
Gross profit$12.0M-40.9%
Operating income-$2.9M-375%
Net income-$3.1M-5,426%
EPS (diluted)-$0.02

Balance sheet

See full
Cash & equivalents$12.2M+124%
Total debt$15.0M-34.9%
Total equity$48.6M+10.8%
Total assets$78.0M-18.6%

Cash flow

See full
Operating cash flow-$2.1M-265%
CapEx$194.0K-83.7%
Free cash flow-$2.3M-2,753%

Valuation

See full
Market cap$59.05M-32.5%
Enterprise value$61.89M-41.5%
P/E32.3×
P/S0.5×-0.2×

Profitability

See full
Gross margin62.3%+4.2pp
Operating margin4.8%+2.8pp
Net margin1.5%+0.8pp
FCF margin6.4%+4.1pp

Returns & leverage

See full
Return on equity3.9%+2.1pp
Debt / equity0.3×-0.2×
Current ratio3.3×+1.0×

Where this comes from

Reported directly by Xtant Medical Holdings in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Xtant Medical Holdings’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xtant Medical Holdings's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xtant Medical Holdings's D&A?
Xtant Medical Holdings (XTNT) reported D&A of $534K in Q1 2026.
How has Xtant Medical Holdings's D&A changed year-over-year?
Xtant Medical Holdings's D&A decreased by 50.3% year-over-year, from $1.07M to $534K.
What is the long-term trend for Xtant Medical Holdings's D&A?
Over 4 years (2021 to 2025), Xtant Medical Holdings's D&A has grown at a 40.7% compound annual growth rate (CAGR), from $1.33M to $5.22M.
What does D&A mean?
Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.